AEMD - aethlonmedical.com PEG multiplikatori
Aethlon Medical (AEMD) uchun PEG past baholanganlik ko'rsatkichi dinamikasi o'sma markerlari va viruslarni olib tashlash uchun mo'ljallangan Hemopurifier filtrlarining chiqarilishi bilan bog'liq bo'lib, bu tartibga soluvchi o'zgarishlar xavfini yumshatadi. 0.00 belgisi tor biznes profili uchun baholash darajasini ko'rsatadi, bunda testlar yakunlanishigacha bo'lgan binar risklar onkologik salohiyat bilan muvozanatlashgan. Terapiya barqarorligi optimallashtirilgan tibbiy logistika va tizimlarning shifoxonalarga tezkor yetkazib berilishi orqali ta'minlanadi.
Aethlon Medical (AEMD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Aethlon Medical|AEMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati aethlonmedical.com|AEMD - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Aethlon|AEMD - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Aethlon Medical|Shoshilinch likvidlik koeffitsiyenti aethlonmedical.com
- foyda va bozor koeffitsiyentlari statistikasi:
AEMD - Sof foyda|Kompaniya foydasi prognozi Aethlon Medical|AEMD - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Aethlon Medical Corp|AEMD - PEG multiplikatori|EV/EBITDA multiplikatori Aethlon|AEMD - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Aethlon Medical|AEMD - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi aethlonmedical.com|AEMD - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Aethlon Medical
Kompaniyaning fundamental tahlili:AEMD (Aethlon Medical Inc)
P/E koeffitsiyenti va EPS o'sishining tahlili Aethlon Medical (AEMD) kompaniyasining Hemopurifier texnologiyasi orqali qon filtratsiyasi sohasidagi innovator sifatidagi bozor holatini baholash imkonini beradi. Ushbu metrika joriy foyda multiplikatorini uning o'sish sur'ati bilan bog'laydi, bunda birdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi va fundamental o'sish potentsialini yoki korreksiya xavfini belgilaydi.
Raqobatdosh kompaniyalar
DXCM - O‘sish sur’atiga tuzatilgan narx-foyda|Penumbra Corp - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Novanta Photonics NOVT|HAE: Narx-foyda va o‘sish multiplikatori|inspiresleep.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PRCT: PEG multiplikatori|CNMD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PLSE (Pulse Corp) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori InMode MD (INMD)|Narx-foyda va o‘sish multiplikatori PMI (Picard Medical Inc)|SRDX (surmodics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Senseonics Holdings Inc SENS|NPCE - Narx-foyda va o‘sish multiplikatori|Tactile Systems Technology Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda SANUWAVE Health Inc|OM: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ELMD|LNSR (LENSAR) - PEG multiplikatori|AVITA Medical Inc. (RCEL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori PROF|Narx-foyda va o‘sish multiplikatori bairdmed.com BDMD|PEG multiplikatori EDAP (EDAP TMS)|PEG multiplikatori Apyx Medical Corp APYX|ICCM - Narxning foydaga va o‘sish sur’atiga nisbati|LUNG: Narxning foydaga va o‘sish sur’atiga nisbati|TELA (telabio.com) - Narx-foyda va o‘sish multiplikatori|CytoSorbents Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SRTS (Sensus Healthcare, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda zynex.com ZYXI|Narxning foydaga va o‘sish sur’atiga nisbati electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Narxning sof foyda o‘sishiga nisbati|Inspira Technologies - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PFSA (Profusa Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati STRATA Skin Sciences Inc.|Narx-foyda va o‘sish multiplikatori GlucoTrack Inc. (GCTK)|PEG multiplikatori NAOV|VERO - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Nuwellis NUWE|ASXC: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AVGR: Narx-foyda va o‘sish multiplikatori|BioSig Technologies - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CUTR: PEG multiplikatori|knowlabs.co (KNW) - PEG multiplikatori|NARI (Inari Medical) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Nevro Corp NVRO|Narx-foyda va o‘sish multiplikatori RSLS (ReShape Lifesciences)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SILK
